Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells

Amyloid Precursor-Like Protein 2 Increases the Endocytosis, Instability, and Turnover of the H2-Kd MHC Class I Molecule

(2014) A. Tuli et al.   JOURNAL OF IMMUNOLOGY

Regulation of apoptosis by Bat3-enhanced YWK-II/APLP2 protein stability

(2012) W. Wu et al.   JOURNAL OF CELL SCIENCE

Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2

(2011) Haley L. Peters et al.   IMMUNOLOGIC RESEARCH

Radiation recall myositis in pediatric Ewing sarcoma

(2011) Jona Hattangadi et al.   PEDIATRIC BLOOD & CANCER

Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement

(2011) Mark A. Applebaum et al.   PEDIATRIC BLOOD & CANCER

Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma

(2011) Jeremy M. Sharib et al.   PEDIATRIC BLOOD & CANCER

Risk of recurrence and survival after relapse in patients with Ewing sarcoma

(2011) Martin Stahl et al.   PEDIATRIC BLOOD & CANCER

Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors

(2010) D. Cho et al.   CLINICAL CANCER RESEARCH

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)

(2010) Pierpaolo Correale et al.   EUROPEAN JOURNAL OF CANCER

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2009) M. Paulussen et al.   ANNALS OF ONCOLOGY

Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target

(2009) D Herrero-Martín et al.   BRITISH JOURNAL OF CANCER

Amyloid precursor-like protein 2 association with HLA class I molecules

(2009) Amit Tuli et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Mechanism for Amyloid Precursor-like Protein 2 Enhancement of Major Histocompatibility Complex Class I Molecule Degradation

(2009) Amit Tuli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma

(2009) Robert Owen Dillman et al.   JOURNAL OF IMMUNOTHERAPY

A Combination Therapy of Gemcitabine With Immunotherapy for Patients With Inoperable Locally Advanced Pancreatic Cancer

(2009) Yoshiki Hirooka et al.   PANCREAS

Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks

(2009) M. Stante et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways

(2008) Dirk H.J. Verhoeven et al.   MOLECULAR IMMUNOLOGY

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

Endolymphatic Immunotherapy in Inoperable Hepatocellular Carcinoma

(2008) R. Bertelli et al.   TRANSPLANTATION PROCEEDINGS

The FE65 proteins and Alzheimer's disease

(2007) Declan M. McLoughlin et al.   JOURNAL OF NEUROSCIENCE RESEARCH